FindTrial
Sign In

Supplementation effect of the milk protein in women's health bone in postmenopausal in a lifestyle modification program with exercise.

Supplementation Effect of Whey Protein in Bone Health Women in Postmenopausal in Modification Program Lifestyle with Exercises Physical and Food Adequacy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7kkd97
Enrollment
Unknown
Registered
2017-07-03
Start date
2016-02-22
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

food intake- SP6.056.237, bone density - G11.427.100, exercise - G11.427.590.530.698.277 I03.350, post-menopause - G08.686.157.500.625, nutritional supplementation - SP6.051.227.

Interventions

The intervention will be made by taking the whey protein, which women aged over 45 years and amenorrhea of at least 12 months without fractures in the last 6 months and attend the program "Healthy Eat
Control Group B: 13 women practicing supervised physical exercise, 3 times a week, lasting 120 minutes will not take supplementation of WP. The evaluations will be at time 0 (M0), after 10 weeks at th
Dietary supplement
SP6.056.237
G11.427.100
G11.427.590.530.698.277
SP6.051.227

Sponsors

Faculdade de Medicina de Botucatu
Lead Sponsor
Faculdade de Medicina de Botucatu
Collaborator

Eligibility

Sex/Gender
Female
Age
45 Years to 90 Years

Inclusion criteria

Inclusion criteria: Women; age less than 45; Amenorrhea greater than twelve months; bone densitometry in the last twelve months; bone above (higher) than - 2.4 SD; Availability participate in physical exercise programs of study.

Exclusion criteria

Exclusion criteria: Low bone mass by densitometry below than 2.5 SD negative; serious and neurological disorders; osteo-articular; uncontrolled metabolic; renal failure or creatinine above 1.5 mg by dL and musculoskeletal disease that impede the realization of physical exercise; Use of drugs that interfere with bone metabolism (estrogen, testosterone, bisphosphonates, raloxifene, calcitonin, fluorida, corticosteroids and calcium) antireabsortivo and anticonvulsants; History of malignancy; bone fracture occurred in the last six month.

Design outcomes

Primary

MeasureTime frame
Improvement of bone health in the 20-week period, from the effect of milk whey protein supplementation, verified by blood analysis by bone marker considering 80% power and 5% margin of error for the sample calculation.—

Secondary

MeasureTime frame
Secondary outcomes are not expected—

Countries

Brazil

Contacts

Public ContactLoraine Gollino

Faculdade de Medicina de Botucatu

logollino@gmail.com+55(16)981104477

Outcome results

None listed

Source: REBEC (via WHO ICTRP)